In “Acknowledgments” on page 2621 of the 12 December 2017 issue, funding from British Heart Foundation grant RG/15/2/31224 was not mentioned. The error has been corrected in the published article.
© 2018 by The American Society of Hematology
2018
Advertisement intended for health care professionals
Bye AP, Unsworth AJ, Desborough MJ, et al. Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib. Blood Adv. 2017;1(26):2610-2623.. Blood Adv 2018; 2 (23): 3515. doi: https://doi.org/10.1182/bloodadvances.2018028944
Download citation file:
In “Acknowledgments” on page 2621 of the 12 December 2017 issue, funding from British Heart Foundation grant RG/15/2/31224 was not mentioned. The error has been corrected in the published article.
Advertisement intended for health care professionals
Advertisement intended for health care professionals
Advertisement intended for health care professionals
Advertisement intended for health care professionals